Health-related quality of life in patients with inflammatory bowel disease: A single-center experience

Annals of Gastroenterology

Volumn 26, Issue 3, 2013, Pages 243-248

  Kalafateli, Maria ^a   Triantos, Christos ^a   Theocharis, Georgios ^a   Giannakopoulou, Dimitra ^a   Koutroumpakis, Efstratios ^a   Chronis, Aristidis ^a   Sapountzis, Apostolos ^a   Margaritis, Vasileios ^a   Thomopoulos, Konstantinos ^a   Nikolopoulou, Vasiliki ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Crohn's disease; Inflammatory bowel diseases; Quality of life; Ulcerative colitis

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CROHN DISEASE; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; EMOTIONAL FUNCTION; ENTERITIS; FEMALE; GASTROINTESTINAL SYMPTOM; GREECE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; QUALITY OF LIFE; SCORING SYSTEM; SEX; SMOKING; SOCIAL STATUS; SYSTEMIC SYMPTOM; ULCERATIVE COLITIS;

EID: 84879441620     PISSN: 11087471     EISSN: 17927463     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ekbom A, Helmick C, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992;103:954-960.
2. Ross SC, Strachan J, Russell RK, Wilson SL. Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;53:480-488.
3. Pallis AG, Mouzas IA. Quality of health care in inflammatory bowel disease and its assessment. Ann Gastroenterol 2002;15:143-147.
4. Mouzas IA, Pallis AG. Assessing quality of life in medical trials on patients with inflammatory bowel disease. Ann Gastroenterol 2000;13:261-263.
5. Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006;4:1491-1501.
6. Zhou Y, Ren W, Irvine EJ, Yang D. Assessing health-related quality of life in patients with inflammatory bowel disease in Zhejiang, China. J Clin Nurs 2010;19:79-88.
7. Romberg-Camps MJL, Bol Y, Dagnelie PC, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBDSouth Limburg Cohort. Inflamm Bowel Dis 2010;16:2137-2147.
8. Mnif L, Mzid A, Amouri A, Chtourou L, Tahri N. Health-related quality of life in patients with inflammatory bowel disease: a Tunisian study. Tunis Med 2010;88:933-936.
9. Moser G. Depression and anxiety in inflammatory bowel disease. Gastroenterol Hepatol 2009;32(Suppl 2):9-12.
10. Jaghult S, Saboonchi F, Johansson UB, Wredling R, Kapraali M. Identifying predictors of low health-related quality of life among patients with inflammatory bowel disease: comparison between Crohn's disease and ulcerative colitis with disease duration. J Clin Nurs 2011;20:1578-1587.
11. Haapamaki J, Turunen U, Roine RP, Farkkila MA, Arkkila PET. Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res 2009;18:961-969.
12. Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease in Crete, Greece. BMC Gastroenterol 2002;2:1.
13. Hoivik ML, Moum B, Solberg IC, et al.; IBSEN Study Group. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflamm Bowel Dis 2012;18:1540-1549.
14. Bernklev T, Jahnsen J, Schulz T, et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol 2005;17:1037-1045.
15. Vogelaar L, Spijker AV, van der Woude CJ. The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clin Exp Gastroenterol 2009;2:101-109.
16. Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995;30:699-706.
17. Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006;12:543-550.
18. Wolters FL, Russel MG, Sijbrandij J, et al. Disease outcome of inflammatory bowel disease patients: general outline of a Europewide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl 2006;243:46-54.
19. Pallis AG, Vlachonikolis IG, Mouzas IA. Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnaire. Digestion 2001;63:240-246.
20. Irvine EJ. Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality of life instrument for adult patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999;28:23-27.
21. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955;ii:1041-1048.
22. Hyphantis TN, Tomenson B, Bai M, Tsianos E, Mavreas V, Creed F. Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Dig Dis Sci 2010;55:724-732.
23. Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389-396.
24. Casellas F, Lopez-Vinancos J, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol 2001;13:567-572.
25. Casellas F, Arenas JI, Baudet JS, et al. Impairement of healthrelated quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005;11:488-496.
26. Gray WN, Denson LA, Baldassano RN, Hommel KA. Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1581-1586.
27. Ulitsky A, Ananathakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel diseases: association with disease activity and quality of life. J Parent Enter Nutr 2011;35:308-316.
28. Irvine EJ. Quality of life in inflammatory bowel disease: biases and other factors affecting scores. Scand J Gastroenterol Suppl 1995;208:136-140.
29. Casellas F, Lopez-Vinancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res 2002;11:775-781.
30. Rubin GP, Hungin APS, Chinn DJ, Dwarakanath D. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Aliment Pharmacol Ther 2004;19:529-535.
31. Kim WH, Cho YS, Yoo HM, Park IS, Park EC, Lim JG. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behcet's disease. Int J Col Dis 1999;14:52-57.
32. Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989;34:1379-1386.
33. Maunder A, Toner B, De Rooy E, Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can J Gastroenterol 1999;13:728-732.
34. De Rooy EC, Toner BB, Maunder RG, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 2001;96:1816-1821.
35. Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I. Reference of norm values as part of documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 1996;221:8-13.
36. Hjortswang H, Jarnerot G, Curman B, et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2003;15:1011-1020.
37. Kuriyama M, Kato J, Kuwaki K, et al. Clinical factors that impair health-related quality pf life in ulcerative colitis patients vary with the disease duration. Eur J Gastroenterol Hepatol 2008;20:634-641.
38. Gibson PR, Weston AR, Shann A, et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol 2007;22:1306-1312.
39. Akerkar GA, Peppercorn MA. Inflammtory bowel disease in the elderly. Practical treatment guidelines. Age Ageing 1997;10:199-208.
40. Gupta S, Saverymuttu SH, Keshavarzian A, Hodgson HJ. Is the pattern of inflammatory bowel disease different in the elderly? Age Ageing 1985;14:366-370.
41. Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;21:499-508.
42. Von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis 2006;12:1175-1184.
43. Timmer A, Preiss JC, Motschall E, Rucker G, Jantschek G, Moser G. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2011;16:CD006913.
44. Boye B, Lundin KE, Jantschek G, et al. INSPIRE study: Does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis 2011;17:1863-1873.